Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1996 1
1997 1
1998 1
1999 2
2001 1
2002 1
2003 1
2007 2
2010 1
2011 1
2014 3
2015 2
2016 1
2017 2
2018 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J. Cornely OA, et al. Among authors: van iersel mlps. J Antimicrob Chemother. 2017 Dec 1;72(12):3406-3413. doi: 10.1093/jac/dkx263. J Antimicrob Chemother. 2017. PMID: 28961714 Clinical Trial.
Metabolism and excretion of asenapine in healthy male subjects.
van de Wetering-Krebbers SF, Jacobs PL, Kemperman GJ, Spaans E, Peeters PA, Delbressine LP, van Iersel ML. van de Wetering-Krebbers SF, et al. Among authors: van iersel ml. Drug Metab Dispos. 2011 Apr;39(4):580-90. doi: 10.1124/dmd.110.036715. Epub 2010 Dec 22. Drug Metab Dispos. 2011. PMID: 21177986 Clinical Trial.
Erratum for Kersemaekers et al., Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects.
Kersemaekers WM, van Iersel T, Nassander U, O'Mara E, Waskin H, Caceres M, van Iersel ML. Kersemaekers WM, et al. Among authors: van iersel ml. Antimicrob Agents Chemother. 2016 Jun 20;60(7):4426. doi: 10.1128/AAC.01001-16. Print 2016 Jul. Antimicrob Agents Chemother. 2016. PMID: 27325815 Free PMC article. No abstract available.
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J. Cornely OA, et al. Among authors: van iersel mlps. J Antimicrob Chemother. 2017 Dec 1;72(12):3501. doi: 10.1093/jac/dkx382. J Antimicrob Chemother. 2017. PMID: 29029280 No abstract available.
Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin.
van Zanden JJ, Ben Hamman O, van Iersel ML, Boeren S, Cnubben NH, Lo Bello M, Vervoort J, van Bladeren PJ, Rietjens IM. van Zanden JJ, et al. Among authors: van iersel ml. Chem Biol Interact. 2003 May 6;145(2):139-48. doi: 10.1016/s0009-2797(02)00250-8. Chem Biol Interact. 2003. PMID: 12686490
22 results